DUBLIN, Nov. 15, 2018 /PRNewswire/ --
The "Global Canine Arthritis Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The Global Canine Arthritis Treatment Market is projected to grow at a CAGR of 4.71% during the period 2019-2023.
One trend affecting this market is the advent of regenerative therapies. Most of the established companies in the global canine arthritis treatment market are focused on conducting extensive research on the treatment of life-threatening disorders by using stem cell therapy.
According to the report, one driver influencing this market is the growing consolidation in the industry. Strategic alliances such as mergers, acquisitions, and collaborations help in co-development and commercialization of drugs in different regions.
Further, the report states that one challenge affecting this market is the stringent drug approval process. Stringent regulatory guidelines for the approval of animal drugs are acting as a major challenge for the growth of the market.
Key Vendors
- Bayer
- Boehringer Ingelheim
- Eli Lilly
- Vetoquinol
- Zoetis
Topics Covered
1. Executive Summary
2. Scope of the Report
3. Market Landscape
4. Market Sizing
5. Five Forces Analysis
6. Market Segmentation by Product
7. Customer Landscape
8. Geographic Landscape
9. Decision Framework
10. Drivers and Challenges
11. Market Trends
12. Vendor Landscape
13. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/qxxqdx/global_canine?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article